Close
Help
Need Help?



Translational Oncogenomics Added to Gale Academic OneFile

Posted Tue, Jun, 05,2012

Libertas is pleased to announce that Translational Oncogenomics has now been added to Gale's Academic OneFile database.

GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Translational Oncogenomics in GALE's Academic OneFile will increase article visibility in North America.

In addition to it's American popularity, GALE has offices in Europe, the Middle East, Africa, Asia, Australia, New Zealand and Latin America. Libertas' partnership with GALE will provide a further strengthening of the already substantial visibility achieved by Translational Oncogenomics, and make articles published in the journal accessible to an even larger audience around the world.

To see where else the journal is indexed, visit the Translational Oncogenomics homepage

share on

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
Since my first enquiry about publishing in Gene Regulation And Systems Biology until the last moment of completing all the steps for publishing my paper, I was always taken seriously as author.  All my questions and concerns were answered in a very professional way.  The review process was quick and very fair.  Reviewers stick to the facts and declare their points of view like a clear thread through the manuscript.  I always had an enthusiastic ...
Dr Jasmine Kharazmi (University of Zurich, Irchel, Zurich, Switzerland)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results